| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/11/2008 | US7341995 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 03/11/2008 | CA2335104C Arylalkanoylpyridazines |
| 03/06/2008 | WO2008026704A1 Isoquinoline derivative |
| 03/06/2008 | WO2008026687A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative |
| 03/06/2008 | WO2008025822A1 Diazolodiazine derivatives as kinase inhibitors |
| 03/06/2008 | WO2008025816A1 Polymorphic crystal form of a indan-2-ylamino-hydroxyethyl-quinolinone maleate derivative as beta-adrenoceptor agonist |
| 03/06/2008 | WO2008025787A2 Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases |
| 03/06/2008 | WO2008025541A1 Polymorph of (r) -3- (2-hydroxy-2, 2-diphenyl-acetoxy) -1- (isoxazol-s-ylcarbamoyl-methyl) -1-azoni a-bicyclo- [2.2.2] octane bromide |
| 03/06/2008 | WO2008025069A1 Methods of modulating cellular activity and compositions therefor |
| 03/06/2008 | WO2008008327A3 Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound |
| 03/06/2008 | WO2007100664A3 Modulators of muscarinic receptors |
| 03/06/2008 | US20080058366 Rhinitis Treatment Regimens |
| 03/06/2008 | US20080058354 Treating erectile dysfunction and female sexual dysfunction; side effect reduction; 1-ethyl-3-(2-hydroxyethyl)-7-(3-bromo-4-methoxyphenyl)-8-(2-hydroxycyclopenylamino)-1,2,3,6-tetrahydro-7H-purine-2,6-dione for example |
| 03/06/2008 | US20080058335 Pain, inflammatory or immune disorders, neurological disorders, cancers of the immune system, respiratory disorders, cardiovascular disorders, neuroprotection; e.g. 5-chloro-N-[(2Z)-5-(1-hydroxy-1-methylethyl)-3-[((cis)-3-methoxycyclobutyl)methyl]-4-methyl-1,3-thiazol-2(3H)-ylidene]-2-methoxybenzamide |
| 03/06/2008 | US20080058311 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example |
| 03/06/2008 | US20080058296 Formulations and methods for treating rhinosinusitis |
| 03/06/2008 | US20080058293 Quinoline Derivates and Their Use in Therapy |
| 03/06/2008 | US20080058278 Reduce oxygen toxicity in lung diseases, dysplasia in premature infants; plasmid for coding sequence |
| 03/06/2008 | US20080058252 Use of C5A receptor antagonist in the treatment of fibrosis |
| 03/06/2008 | US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 03/06/2008 | US20080057129 Deposited by sublimation onto a carrier chosen from lactose, dextran, dextrose, and mannitol, and are suitable for administration by inhalation or injection; lung infections in patients with cystic fibrosis; calcitrol, azithromycin; improved bioavailability |
| 03/06/2008 | US20080057003 Powder inhaler formulations |
| 03/06/2008 | US20080053430 Aerosol formulation for the inhalation of beta agonists |
| 03/06/2008 | CA2661850A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same |
| 03/06/2008 | CA2660983A1 Polymorph of (r) -3- (2-hydroxy-2, 2-diphenyl-acetoxy) -1- (isoxazol-3-ylcarbamoyl-methyl) -1-azoni a-bicyclo- [2.2.2] octane bromide |
| 03/06/2008 | CA2659339A1 Organic compounds |
| 03/06/2008 | CA2659144A1 Polymorphic crystal form of a indan-2-ylamino-hydroxyethyl-quinolinone maleate derivative as beta-adrenoceptor agonist |
| 03/05/2008 | EP1894568A1 Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases |
| 03/05/2008 | EP1893752A2 Attenuated sars and use as a vaccine |
| 03/05/2008 | EP1893584A1 Dihydropyrimidone multimers and their use as human neutrophil elastase inhibitors |
| 03/05/2008 | EP1893577A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 03/05/2008 | EP1893203A2 Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor |
| 03/05/2008 | EP1893189A2 Use of hydroxy tetrahydro-naphthalene derivatives for the treatment of respiratory diseases |
| 03/05/2008 | EP1709036B1 Thiazole derivatives as a2b antagonists |
| 03/05/2008 | EP1633748B1 Quinoline derivatives as phosphodiesterase inhibitors |
| 03/05/2008 | EP1368253B1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
| 03/05/2008 | CN101137654A Novel salt of quinuclidine derivative |
| 03/05/2008 | CN101137391A Recombinant super-compound interferon and uses thereof |
| 03/05/2008 | CN101137366A Compounds for treating autoimmune and demyelinating diseases |
| 03/05/2008 | CN101137361A Potassium channel opener having benzofuroindole skeleton |
| 03/05/2008 | CN101134775A Novel streptococcus antigens |
| 03/05/2008 | CN101134104A Particle medicinal granules for treating pharyngitis and method of producing the same |
| 03/05/2008 | CN101134095A Traditional Chinese medicine composition for treating allergic rhinitis |
| 03/05/2008 | CN101134092A Traditional Chinese medicine compound preparations for treating respiratory disease and method for preparing the same |
| 03/05/2008 | CN101134084A Anti-inflammation liquid |
| 03/05/2008 | CN101134081A Traditional Chinese medicine composition for treating chronic pharyngitis |
| 03/05/2008 | CN101134038A 缓释的口服给药组合物 The sustained-release composition for oral administration |
| 03/05/2008 | CN101133873A Wilding synthesized 3-nut compressed food granules beverage and method of processing the same |
| 03/05/2008 | CN101133792A Wilding synthesized naked oat legume oat compressed granules and orange juice and method of processing the same |
| 03/05/2008 | CN101133791A Wilding synthesized corn, peanut, lotus seed compressed granules and orange juice beverage and method for processing the same |
| 03/05/2008 | CN100372849C Pyrrolo pyrimidine compounds as inhibitor of cysteine protease |
| 03/05/2008 | CN100372846C Sulfonamido substituted imidazopyridines |
| 03/05/2008 | CN100372836C Immunotherapeutic imides/amides |
| 03/05/2008 | CN100372563C Compound preparation for treating bronchitis, its preparation method and quality control method |
| 03/05/2008 | CN100372555C Chinese medicinal granule for clearing pharynx and moistening throat and preparation method thereof |
| 03/05/2008 | CN100372532C Imidazolin-2-ylaminophenyl amides as IP antagonists. |
| 03/05/2008 | CN100372520C Preparing method of scalded leech medicine granule |
| 03/04/2008 | US7338953 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 03/04/2008 | US7338658 Chimeric antibody specific to human CD4 which comprises the variable heavy and light chain sequences of an Old World monkey monoclonal antibody produced against human CD4 and human constant heavy and light domain sequences |
| 02/28/2008 | WO2008024715A2 Tonsillitis treatment |
| 02/28/2008 | WO2008024700A2 Tonsillitis treatment |
| 02/28/2008 | WO2008024433A2 Haloalkyl-substituted pyrimidinone derivatives |
| 02/28/2008 | WO2008024020A1 Liposomal composition of antioxidants for inhalations carried out during lung and upper respiratory tract diseases |
| 02/28/2008 | WO2008023446A1 Remedy for chronic obstructive pulmonary disease |
| 02/28/2008 | WO2008023157A1 Nitrogen containing heterocyclic compounds useful as m3-receptor modulators |
| 02/28/2008 | WO2008023005A1 Aerosol formulation for the inhalation of beta-agonists |
| 02/28/2008 | WO2008023004A1 Single enantiomer beta agonists method for production and use thereof as a medicament |
| 02/28/2008 | WO2008023003A1 Drug combinations for treating airway diseases |
| 02/28/2008 | WO2008023001A1 Powder formulations for inhalation containing enantiomerically pure beta-agonists |
| 02/28/2008 | WO2008006295B1 New optical active phenylethanol amines and preparing method thereof |
| 02/28/2008 | WO2008003612A3 Analogs of vasoactive intestinal peptide |
| 02/28/2008 | WO2007138282A3 Bi-aryl or aryl-heteroaryl substituted indoles |
| 02/28/2008 | WO2007110678A3 Neutralizing antibodies and methods of use thereof |
| 02/28/2008 | US20080051434 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 02/28/2008 | US20080051397 with polyglycolized glyceride (macrogol glyceride); Gelucires"; multiple sclerosis, asthma, scleroderma, endometriosis; 1,3-benzothiazol-2(3H)-ylidene{2-[(1,4-dimethylpiperazin-2-yl)methoxy]pyrimidin-4-yl}acetonitrile; adding to melt as powder under stirring resulting in homogeneous molten dispersion |
| 02/28/2008 | US20080051392 Pharmaceutical combinations for the treatment of respiratory diseases |
| 02/28/2008 | US20080051378 Combinations Comprising Antimuscarinic Agents and Corticosteroids |
| 02/28/2008 | US20080051356 Truncated 24kDa basic fibroblast growth factor |
| 02/28/2008 | US20080051338 98 Human Secreted Proteins |
| 02/28/2008 | US20080050444 Pharmaceutical compositions of ilaparazole |
| 02/28/2008 | US20080050439 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections |
| 02/28/2008 | US20080050414 Methods For Treating Or Preventing Restenosis And Other Vascular Proliferative Disorders |
| 02/28/2008 | US20080050378 A ribonucleotide sequence corresponding to a gene KIF11 target sequence, where the antisense strand comprises a ribonucleotide sequence complementary to the sense strand; sense/anntisense strands hybridize to form double-stranded molecule which inhibits cell expression of KIf11 (SEQ ID NO: 34) |
| 02/28/2008 | US20080050368 Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 02/28/2008 | US20080050315 Diagnostics and Therapeutics for Diseases Associated with Protein Kinase, Cgmp-Dependent, Type I (Prkg1) |
| 02/28/2008 | US20080050314 Diagnostics and Therapeutics for Diseases Associated With Glycogen Synthase Kinase 3 Beta (Gsk3b) |
| 02/28/2008 | DE602004007105T2 Zusammensetzung zur behandlung von gastrointestinalen störungen Composition for the treatment of gastrointestinal disorders |
| 02/28/2008 | CA2675942A1 Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists |
| 02/28/2008 | CA2661496A1 Pharmaceutical combinations for the treatment of respiratory diseases |
| 02/28/2008 | CA2661481A1 Powder formulations for inhalation containing enantiomerically pure beta-agonists |
| 02/28/2008 | CA2661442A1 Aerosol formulation for the inhalation of beta-agonists |
| 02/28/2008 | CA2661143A1 Enantiomerically pure beta agonists, manufacturing and use thereof |
| 02/28/2008 | CA2661044A1 Kw-3902 conjugates that do not cross the blood-brain barrier |
| 02/28/2008 | CA2660957A1 2-phenoxy pyrimidinone analogues |
| 02/28/2008 | CA2660951A1 Haloalkyl-substituted pyrimidinone derivatives |
| 02/27/2008 | EP1892299A2 Sense mRNA therapy |
| 02/27/2008 | EP1892293A1 Transcription factor decoy |
| 02/27/2008 | EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/27/2008 | EP1892241A1 Novel piperidine derivative |
| 02/27/2008 | EP1892239A1 Inhibitors of cytosolic phospholipase A2 |